Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Anti-Apoptotic Bcl-2 Family Member Mcl-1 Promotes T Lymphocyte Survival at Multiple Stages
Ivan Dzhagalov, Alexis Dunkle, You-Wen He
The Journal of Immunology (2008) Vol. 181, Iss. 1, pp. 521-528
Open Access | Times Cited: 147

Showing 1-25 of 147 citing articles:

Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration
Rhonda M. Perciavalle, Daniel P. Stewart, Brian Koss, et al.
Nature Cell Biology (2012) Vol. 14, Iss. 6, pp. 575-583
Open Access | Times Cited: 366
Decision checkpoints in the thymus
Andrea C. Carpenter, Rémy Bosselut
Nature Immunology (2010) Vol. 11, Iss. 8, pp. 666-673
Open Access | Times Cited: 294
Anti-apoptotic BCL-2 family members in development
Joseph T. Opferman, Anisha Kothari
Cell Death and Differentiation (2017) Vol. 25, Iss. 1, pp. 37-45
Open Access | Times Cited: 293
Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction
Xi Wang, Madhavi Bathina, J.A. Lynch, et al.
Genes & Development (2013) Vol. 27, Iss. 12, pp. 1351-1364
Open Access | Times Cited: 237
IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis
Florent Carrette, Charles D. Surh
Seminars in Immunology (2012) Vol. 24, Iss. 3, pp. 209-217
Open Access | Times Cited: 226
Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3+ regulatory T cells
Wim Pierson, Bénédicte Cauwe, Antonia N. Policheni, et al.
Nature Immunology (2013) Vol. 14, Iss. 9, pp. 959-965
Open Access | Times Cited: 220
Delving deeper: MCL-1's contributions to normal and cancer biology
Rhonda M. Perciavalle, Joseph T. Opferman
Trends in Cell Biology (2012) Vol. 23, Iss. 1, pp. 22-29
Open Access | Times Cited: 214
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Ilio Vitale, Federico Pietrocola, Emma Guilbaud, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1097-1154
Open Access | Times Cited: 207
Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression
Dewan Md Sakib Hossain, Sarah Javaid, Mingmei Cai, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 2, pp. 644-654
Open Access | Times Cited: 189
Interleukin-7 Biology and Its Effects on Immune Cells: Mediator of Generation, Differentiation, Survival, and Homeostasis
Deng Chen, Ting-Xuan Tang, Hai Deng, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 137
The multiple mechanisms of MCL1 in the regulation of cell fate
Hayley Widden, William J. Placzek
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 103
Sulfated bile acid is a host-derived ligand for MAIT cells
E. Ito, Shinsuke Inuki, Yoshihiro Izumi, et al.
Science Immunology (2024) Vol. 9, Iss. 91
Open Access | Times Cited: 20
Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice
Jennifer N. Lilla, Ching‐Cheng Chen, Kaori Mukai, et al.
Blood (2011) Vol. 118, Iss. 26, pp. 6930-6938
Open Access | Times Cited: 189
Mcl-1 Ubiquitination: Unique Regulation of an Essential Survival Protein
Barbara Mojsa, Irina Lassot, Solange Desagher
Cells (2014) Vol. 3, Iss. 2, pp. 418-437
Open Access | Times Cited: 167
Small molecule Mcl-1 inhibitors for the treatment of cancer
Johannes Belmar, Stephen W. Fesik
Pharmacology & Therapeutics (2014) Vol. 145, pp. 76-84
Open Access | Times Cited: 161
Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity
Milan Bruncko, Le Wang, George S. Sheppard, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 5, pp. 2180-2194
Closed Access | Times Cited: 145
ER functions of oncogenes and tumor suppressors: Modulators of intracellular Ca2+ signaling
Mart Bittremieux, Jan B. Parys, Paolo Pinton, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2016) Vol. 1863, Iss. 6, pp. 1364-1378
Open Access | Times Cited: 133
Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance
Kirsteen J. Campbell, Mary L. Bath, Marian L. Turner, et al.
Blood (2010) Vol. 116, Iss. 17, pp. 3197-3207
Open Access | Times Cited: 130
Heightened mitochondrial priming is the basis for apoptotic hypersensitivity of CD4+CD8+thymocytes
Jeremy Ryan, Joslyn K. Brunelle, Anthony Letai
Proceedings of the National Academy of Sciences (2010) Vol. 107, Iss. 29, pp. 12895-12900
Open Access | Times Cited: 127
Endothelial cell apoptosis in angiogenesis and vessel regression
Emma C. Watson, Zoe L. Grant, Leigh Coultas
Cellular and Molecular Life Sciences (2017) Vol. 74, Iss. 24, pp. 4387-4403
Open Access | Times Cited: 113
Attacking cancer's Achilles heel: antagonism of anti‐apoptotic BCL‐2 family members
Joseph T. Opferman
FEBS Journal (2015) Vol. 283, Iss. 14, pp. 2661-2675
Open Access | Times Cited: 110
The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1
Marta Larráyoz, Stuart J. Blakemore, Rachel Dobson, et al.
Leukemia (2015) Vol. 30, Iss. 2, pp. 351-360
Closed Access | Times Cited: 93
Life and Death of Activated T Cells: How Are They Different from Naïve T Cells?
Yifan Zhan, Emma M. Carrington, Yuxia Zhang, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 89
It's time to die: BH3 mimetics in solid tumors
Sarah Kehr, Meike Vogler
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2021) Vol. 1868, Iss. 5, pp. 118987-118987
Open Access | Times Cited: 60
BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models
Ulrike Rauh, Wei Guo, Michael H. Serrano‐Wu, et al.
Nature Cancer (2024) Vol. 5, Iss. 10, pp. 1479-1493
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top